BACKGROUND: Due to heterogeneous clinical presentation, difficult differential diagnosis with Alzheimer's disease (AD) and psychiatric disorders, and evolving clinical criteria, the epidemiology and natural history of frontotemporal lobar degeneration (FTD) remain elusive. In order to better characterize FTD patients, we relied on the database of a regional memory clinic network with standardized diagnostic procedures and chose AD patients as a comparator. METHODS: Patients that were first referred to our network between January 2010 and December 2016 and whose last clinical diagnosis was degenerative or vascular dementia were included. Comparisons were conducted between FTD and AD as well as between the different FTD syndromes, divided into language variants (lvFTD), behavioral variant (bvFTD), and FTD with primarily motor symptoms (mFTD). Cognitive progression was estimated with the yearly decline in Mini Mental State Examination (MMSE). RESULTS: Among the patients that were referred to our network in the 6-year time span, 690 were ultimately diagnosed with FTD and 18,831 with AD. Patients with FTD syndromes represented 2.6% of all-cause dementias. The age-standardized incidence was 2.90 per 100,000 person-year and incidence peaked between 75 and 79 years. Compared to AD, patients with FTD syndromes had a longer referral delay and delay to diagnosis. Patients with FTD syndromes had a higher MMSE score than AD at first referral while their progression was similar. mFTD patients had the shortest survival while survival in bvFTD, lvFTD, and AD did not significantly differ. FTD patients, especially those with the behavioral variant, received more antidepressants, anxiolytics, and antipsychotics than AD patients. CONCLUSIONS: FTD syndromes differ with AD in characteristics at baseline, progression rate, and treatment. Despite a broad use of the new diagnostic criteria in an organized memory clinic network, FTD syndromes are longer to diagnose and account for a low proportion of dementia cases, suggesting persistent underdiagnosis. Congruent with recent publications, the late peak of incidence warns against considering FTD as being exclusively a young-onset dementia.
BACKGROUND: Due to heterogeneous clinical presentation, difficult differential diagnosis with Alzheimer's disease (AD) and psychiatric disorders, and evolving clinical criteria, the epidemiology and natural history of frontotemporal lobar degeneration (FTD) remain elusive. In order to better characterize FTDpatients, we relied on the database of a regional memory clinic network with standardized diagnostic procedures and chose ADpatients as a comparator. METHODS:Patients that were first referred to our network between January 2010 and December 2016 and whose last clinical diagnosis was degenerative or vascular dementia were included. Comparisons were conducted between FTD and AD as well as between the different FTD syndromes, divided into language variants (lvFTD), behavioral variant (bvFTD), and FTD with primarily motor symptoms (mFTD). Cognitive progression was estimated with the yearly decline in Mini Mental State Examination (MMSE). RESULTS: Among the patients that were referred to our network in the 6-year time span, 690 were ultimately diagnosed with FTD and 18,831 with AD. Patients with FTD syndromes represented 2.6% of all-cause dementias. The age-standardized incidence was 2.90 per 100,000 person-year and incidence peaked between 75 and 79 years. Compared to AD, patients with FTD syndromes had a longer referral delay and delay to diagnosis. Patients with FTD syndromes had a higher MMSE score than AD at first referral while their progression was similar. mFTD patients had the shortest survival while survival in bvFTD, lvFTD, and AD did not significantly differ. FTDpatients, especially those with the behavioral variant, received more antidepressants, anxiolytics, and antipsychotics than ADpatients. CONCLUSIONS:FTD syndromes differ with AD in characteristics at baseline, progression rate, and treatment. Despite a broad use of the new diagnostic criteria in an organized memory clinic network, FTD syndromes are longer to diagnose and account for a low proportion of dementia cases, suggesting persistent underdiagnosis. Congruent with recent publications, the late peak of incidence warns against considering FTD as being exclusively a young-onset dementia.
Authors: D van Vliet; M E de Vugt; C Bakker; Y A L Pijnenburg; M J F J Vernooij-Dassen; R T C M Koopmans; F R J Verhey Journal: Psychol Med Date: 2012-05-28 Impact factor: 7.723
Authors: Sang Won Seo; Marie-Pierre Thibodeau; David C Perry; Alice Hua; Manu Sidhu; Isabel Sible; Jose Norberto S Vargas; Stephanie E Gaus; Gil D Rabinovici; Katherine D Rankin; Adam L Boxer; Joel H Kramer; Howard J Rosen; Maria Luisa Gorno-Tempini; Lea T Grinberg; Eric J Huang; Stephen J DeArmond; John Q Trojanowski; Bruce L Miller; William W Seeley Journal: Neurology Date: 2018-02-16 Impact factor: 9.910
Authors: Hulya Ulugut Erkoyun; Colin Groot; Ronja Heilbron; Anne Nelissen; Jonathan van Rossum; Roos Jutten; Ted Koene; Wiesje M van der Flier; Mike P Wattjes; Philip Scheltens; Rik Ossenkoppele; Frederik Barkhof; Yolande Pijnenburg Journal: Brain Date: 2020-09-01 Impact factor: 15.255
Authors: Jay L P Fieldhouse; Flora T Gossink; Thomas C Feenstra; Sterre C M de Boer; Afina W Lemstra; Niels D Prins; Femke Bouwman; Ted Koene; Hanneke F M Rhodius-Meester; Freek Gillissen; Charlotte E Teunissen; Wiesje M van der Flier; Philip Scheltens; Annemieke Dols; Everard G B Vijverberg; Yolande A L Pijnenburg Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Fernando Henríquez; Victoria Cabello; Sandra Baez; Leonardo Cruz de Souza; Patricia Lillo; David Martínez-Pernía; Loreto Olavarría; Teresa Torralva; Andrea Slachevsky Journal: Front Neurol Date: 2022-02-16 Impact factor: 4.003
Authors: Michael Guger; Stefan Raschbacher; Lukas Kellermair; Milan R Vosko; Christian Eggers; Thomas Forstner; Karin Leitner; Alexandra Fuchs; Franz Fellner; Gerhard Ransmayr Journal: J Neural Transm (Vienna) Date: 2021-07-19 Impact factor: 3.575